What is Regenxbio's operating cash flow?

Regenxbio (RGNX) reported operating cash flow of -$76.19M in Q1 2026.

How has Regenxbio's operating cash flow changed year-over-year?

Regenxbio's operating cash flow decreased by 326.5% year-over-year, from $33.63M to -$76.19M.

What is the long-term trend for Regenxbio's operating cash flow?

Over 4 years (2021 to 2025), Regenxbio's operating cash flow has grown at a -13.2% compound annual growth rate (CAGR), from $218.88M to -$123.96M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Regenxbio RGNX Operating Cash Flow

Operating Cash Flow at other companies

Regeneron PharmaceuticalsREGN

$1.08B+3.2%

Sarepta Therapeutics, Inc.SRPT

-$202.68M+65.3%

BiogenBIIB

$645.5M+149%

BioMarin PharmaceuticalsBMRN

$220.65M+26.5%

EyePoint, Inc. EYPT

-$80.55M-51.6%

Ultragenyx PharmaceuticalRARE

-$197M-18.7%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's operating cash flow?: Regenxbio (RGNX) reported operating cash flow of -$76.19M in Q1 2026.
How has Regenxbio's operating cash flow changed year-over-year?: Regenxbio's operating cash flow decreased by 326.5% year-over-year, from $33.63M to -$76.19M.
What is the long-term trend for Regenxbio's operating cash flow?: Over 4 years (2021 to 2025), Regenxbio's operating cash flow has grown at a -13.2% compound annual growth rate (CAGR), from $218.88M to -$123.96M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.